期刊文献+

科学认识生物类似药,推动生物类似药的合理使用和发展——抗肿瘤生物类似药应用重庆专家共识 被引量:1

To promote the rational use and healthy development of biosimilars through scientific understanding of biosimilars:Chongqing experts consensus on the application of anti-tumor biosimilars
下载PDF
导出
摘要 抗肿瘤生物类似药在肿瘤临床治疗中发挥着重要作用,如何合理应用生物类似药是临床实践必须面对的问题。重庆专家重点探讨了抗肿瘤生物类似药的有效性、安全性、适应证外推及参照药转换问题,对其在临床应用上具有指导意义。 Anti-tumor biosimilars are playing an important role in the clinical treatment of tumors.How to reasonably use biosimilars is a problem that must be faced in clinical practice.Discussion of Chongqing experts focused on the effectiveness,safety,indication extrapolation and conversion between anti-tumor biosimilars and reference drugs,which has guiding significance in clinical application.
作者 单锦露 孙建国 阮志华 任必勇 杨志祥 李毅 田福华 康保国 赵晓辉 刘作金 南映瑜 邓媛 朱宇熹 王东林 陈正堂 王东 SHAN Jinlu;SUN Jianguo;RUAN Zhihua;REN Biyong;YANG Zhixiang;LI Yi;TIAN Fuhua;KANG Baoguo;ZHAO Xiaohui;LIU Zuojin;NAN Yingyu;DENG Yuan;ZHU Yuxi;WANG Donglin;CHEN Zhengtang;WANG dong(Daping Hospital,Army Medical University,Chongqing 400042,China;Xinqiao Hospital,Army Medical University,Chongqing 400037,China;Southwest Hospital,Army Medical University,Chongqing 400038,China;Three Gorges Central Hospital Affiliated to Chongqing University,Chongqing 5001014,China;Chongqing Traditional Chinese Medicine Hospital,Chongqing 400011,China;Beibei Traditional Chinese Medical Hospital,Chongqing 400700,China;People′s Hospital of Jiulongpo District,Chongqing 400050,China;The First People′s Hospital of Chongqing Liang Jiang New Area,Chongqing 401147,China;The Ninth People′s Hospital of Chongqing,Chongqing 400700,China;The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400067,China;Chongqing University Cancer Hospital,Chongqing 400030,China;Chongqing Emergency Medical Center/the Fourth People′s Hospital of Chongqing 400010,China;Jinshan Hospital,the First Affiliated Hospital of Chongqing Medical University,Chongqing 401120,China)
出处 《重庆医学》 CAS 2020年第22期3685-3687,共3页 Chongqing medicine
关键词 肿瘤 生物类似药 有效性 安全性 适应证 专家共识 neoplasms biosimilars effectiveness safety indications expert consensus
  • 相关文献

参考文献2

二级参考文献11

共引文献14

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部